Literature DB >> 24488007

Pressure-overload-induced right heart failure.

S Rain1, M L Handoko, A Vonk Noordegraaf, H J Bogaard, J van der Velden, F S de Man.   

Abstract

Although pulmonary arterial hypertension originates in the lung and is caused by progressive remodeling of the small pulmonary arterioles, patients die from the consequences of pressure-overload-induced right heart failure. Prognosis is poor, and currently there are no selective treatments targeting the failing right ventricle. Therefore, it is of utmost importance to obtain more insights into the mechanisms of right ventricular adaptation and the transition toward right heart failure. In this review, we propose that the same adaptive mechanisms, which initially preserve right ventricular systolic function and maintain cardiac output, eventually initiate the transition toward right heart failure.

Entities:  

Mesh:

Year:  2014        PMID: 24488007     DOI: 10.1007/s00424-014-1450-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  75 in total

Review 1.  Right ventricular adaptation to pressure overload.

Authors:  Marc A Simon
Journal:  Curr Opin Crit Care       Date:  2010-06       Impact factor: 3.687

2.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

Review 3.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

4.  Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study.

Authors:  Andrew J Peacock; Stephen Crawley; Lindsey McLure; Kevin G Blyth; Carmine Dario Vizza; Roberto Poscia; Marco Francone; Ilaria Iacucci; Horst Olschewski; Gabor Kovacs; Anton Vonk Noordegraaf; J Tim Marcus; Marielle C van de Veerdonk; Frank P T Oosterveer
Journal:  Circ Cardiovasc Imaging       Date:  2013-10-30       Impact factor: 7.792

5.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

6.  Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension.

Authors:  Gerrina Ruiter; Yeun Ying Wong; Frances S de Man; M Louis Handoko; Richard T Jaspers; Pieter E Postmus; Nico Westerhof; Hans W M Niessen; Willem J van der Laarse; Anton Vonk-Noordegraaf
Journal:  J Heart Lung Transplant       Date:  2012-11-09       Impact factor: 10.247

7.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

8.  Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning.

Authors:  Asger Andersen; Jonas Agerlund Povlsen; Hans Erik Bøtker; Jens Erik Nielsen-Kudsk
Journal:  Eur J Heart Fail       Date:  2013-06-30       Impact factor: 15.534

9.  Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy.

Authors:  Michael H Radke; Jun Peng; Yiming Wu; Mark McNabb; O Lynne Nelson; Henk Granzier; Michael Gotthardt
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 10.  What is the role of beta-adrenergic signaling in heart failure?

Authors:  Martin J Lohse; Stefan Engelhardt; Thomas Eschenhagen
Journal:  Circ Res       Date:  2003-11-14       Impact factor: 17.367

View more
  10 in total

Review 1.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

2.  Evaluation of Right Ventricular Myocardial Mechanics by 2- and 3-Dimensional Speckle-Tracking Echocardiography in Patients With an Ischemic or Non-ischemic Etiology of End-Stage Heart Failure.

Authors:  Fangyan Tian; Ying Gu; Yanting Zhang; Bei Zhang; Yuji Xie; Shaomei Yu; Shuangshuang Zhu; Wei Sun; Shan Cheng; Mingzu Qian; Yixia Lin; Wenqian Wu; Yali Yang; Qing Lv; Jing Wang; Li Zhang; Yuman Li; Mingxing Xie
Journal:  Front Cardiovasc Med       Date:  2022-05-25

3.  Multiscale Computational Analysis of Right Ventricular Mechanoenergetics.

Authors:  Ryan J Pewowaruk; Jennifer L Philip; Shivendra G Tewari; Claire S Chen; Mark S Nyaeme; Zhijie Wang; Diana M Tabima; Anthony J Baker; Daniel A Beard; Naomi C Chesler
Journal:  J Biomech Eng       Date:  2018-08-01       Impact factor: 2.097

4.  Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.

Authors:  Denielli da Silva Gonçalves Bos; Chris Happé; Ingrid Schalij; Wioletta Pijacka; Julian F R Paton; Christophe Guignabert; Ly Tu; Raphaël Thuillet; Harm-Jan Bogaard; Albert C van Rossum; Anton Vonk-Noordegraaf; Frances S de Man; M Louis Handoko
Journal:  JACC Basic Transl Sci       Date:  2017-02-01

Review 5.  Treatment strategies for the right heart in pulmonary hypertension.

Authors:  Berend E Westerhof; Nabil Saouti; Willem J van der Laarse; Nico Westerhof; Anton Vonk Noordegraaf
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

6.  Changes in heart morphometric parameters over the course of a monocrotaline-induced pulmonary arterial hypertension rat model.

Authors:  Mateusz K Hołda; Elżbieta Szczepanek; Joanna Bielawska; Natalia Palka; Dorota Wojtysiak; Paulina Frączek; Michał Nowakowski; Natalia Sowińska; Zbigniew Arent; Piotr Podolec; Grzegorz Kopeć
Journal:  J Transl Med       Date:  2020-06-30       Impact factor: 5.531

7.  Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.

Authors:  Akira Sugiyama; Maina Kaisho; Muneyoshi Okada; Kosuke Otani; Hideyuki Yamawaki
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

8.  The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis.

Authors:  Yaoshi Hu; Zhe Wei; Chaoyong Zhang; Chuanghong Lu; Zhiyu Zeng
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

9.  Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril Stiffness.

Authors:  Silvia Rain; Stine Andersen; Aref Najafi; Jacob Gammelgaard Schultz; Denielli da Silva Gonçalves Bós; M Louis Handoko; Harm-Jan Bogaard; Anton Vonk-Noordegraaf; Asger Andersen; Jolanda van der Velden; Coen A C Ottenheijm; Frances S de Man
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

10.  Impaired Myofilament Contraction Drives Right Ventricular Failure Secondary to Pressure Overload: Model Simulations, Experimental Validation, and Treatment Predictions.

Authors:  Jennifer L Philip; Ryan J Pewowaruk; Claire S Chen; Diana M Tabima; Daniel A Beard; Anthony J Baker; Naomi C Chesler
Journal:  Front Physiol       Date:  2018-06-27       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.